These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 9579846

  • 1. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
    Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, Kanz L.
    Br J Cancer; 1998 Apr; 77(8):1355-62. PubMed ID: 9579846
    [Abstract] [Full Text] [Related]

  • 2. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
    Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Oncology; 2006 Apr; 70(3):177-84. PubMed ID: 16757924
    [Abstract] [Full Text] [Related]

  • 3. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
    Biró K.
    Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
    [Abstract] [Full Text] [Related]

  • 4. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
    Biró K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Magy Onkol; 2006 Sep; 50(4):329-35. PubMed ID: 17216007
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.
    Sanchez VA, Dinh PC, Monahan PO, Althouse S, Rooker J, Sesso HD, Dolan ME, Weinzerl M, Feldman DR, Fung C, Einhorn LH, Frisina RD, Travis LB.
    JAMA Oncol; 2024 Jul 01; 10(7):912-922. PubMed ID: 38842797
    [Abstract] [Full Text] [Related]

  • 6. Development and validation of a cisplatin dose-ototoxicity model.
    Dille MF, Wilmington D, McMillan GP, Helt W, Fausti SA, Konrad-Martin D.
    J Am Acad Audiol; 2012 Jul 01; 23(7):510-21. PubMed ID: 22992258
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.
    Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB.
    J Clin Oncol; 2016 Aug 10; 34(23):2712-20. PubMed ID: 27354478
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.
    J Pediatr Hematol Oncol; 2004 Oct 10; 26(10):649-55. PubMed ID: 15454836
    [Abstract] [Full Text] [Related]

  • 10. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa.
    Paken J, Govender CD, Pillay M, Ayele BT, Sewram V.
    BMC Cancer; 2021 Jul 16; 21(1):822. PubMed ID: 34271863
    [Abstract] [Full Text] [Related]

  • 11. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.
    Waters GS, Ahmad M, Katsarkas A, Stanimir G, McKay J.
    Ear Hear; 1991 Apr 16; 12(2):91-102. PubMed ID: 2065844
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
    Paken J, Govender CD, Pillay M, Feyasa M, Sewram V.
    PLoS One; 2023 Apr 16; 18(4):e0283639. PubMed ID: 37014872
    [Abstract] [Full Text] [Related]

  • 13. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S, Del Valle Á, Chuang A, Becker A.
    Int J Pediatr Otorhinolaryngol; 2018 Aug 16; 111():174-179. PubMed ID: 29958605
    [Abstract] [Full Text] [Related]

  • 14. Genetic risk factors of cisplatin induced ototoxicity in adult patients.
    Talach T, Rottenberg J, Gal B, Kostrica R, Jurajda M, Kocak I, Lakomy R, Vogazianos E.
    Neoplasma; 2016 Aug 16; 63(2):263-8. PubMed ID: 26774148
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
    Sanchez VA, Dinh PC, Rooker J, Monahan PO, Althouse SK, Fung C, Sesso HD, Einhorn LH, Dolan ME, Frisina RD, Travis LB.
    J Cancer Surviv; 2023 Feb 16; 17(1):27-39. PubMed ID: 36637632
    [Abstract] [Full Text] [Related]

  • 16. Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients.
    Drögemöller BI, Brooks B, Critchley C, Monzon JG, Wright GEB, Liu G, Renouf DJ, Kollmannsberger CK, Bedard PL, Hayden MR, Gelmon KA, Carleton BC, Ross CJD.
    Clin Cancer Res; 2018 Apr 15; 24(8):1866-1871. PubMed ID: 29358504
    [Abstract] [Full Text] [Related]

  • 17. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
    Crabb SJ, Martin K, Abab J, Ratcliffe I, Thornton R, Lineton B, Ellis M, Moody R, Stanton L, Galanopoulou A, Maishman T, Geldart T, Bayne M, Davies J, Lamb C, Popat S, Joffe JK, Nutting C, Chester J, Hartley A, Thomas G, Ottensmeier C, Huddart R, King E.
    Eur J Cancer; 2017 Dec 15; 87():75-83. PubMed ID: 29128692
    [Abstract] [Full Text] [Related]

  • 18. [Ototoxicity of cisplatin in children with malignant diseases].
    Hadjilaskari P, Fengler R, Hartmann R, Henze G.
    Klin Padiatr; 1989 Dec 15; 201(4):316-21. PubMed ID: 2779137
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
    Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ.
    J Clin Oncol; 1996 Nov 15; 14(11):2923-32. PubMed ID: 8918489
    [Abstract] [Full Text] [Related]

  • 20. ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin.
    De Lauretis A, De Capua B, Barbieri MT, Bellussi L, Passàli D.
    Scand Audiol; 1999 Nov 15; 28(3):139-43. PubMed ID: 10489862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.